drugset

drugset / Trial / NCT02162979

Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease

NCT02162979 ↗

Phase 2 Terminated 2 enrolled Loma Linda University

RandomizedCrossoverTriple-blindTreatment

Summary

This study is to determine if Viagra is effective in reducing dyskinesias in patients with Parkinson's Disease.

Timeline

Start: 2002-02
Primary completion: 2009-01
Completion: 2009-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	50 mg	—

Indications